Laparoscopic Device Market Outlook from 2024 to 2034

The laparoscopic device market is anticipated to be worth US$ 13.59 billion in 2024. Companies are using various tactics to deal with supply chain disruptions.

The need for laparoscopic devices is predicted to rise at a sluggish CAGR of 4.2% through 2034. The industry is projected to surpass US$ 20.5 billion by 2034. The surge in the prevalence of obesity across all age groups is raising the market growth.

Attributes Details
Laparoscopic Device Market Value for 2024 US$ 13.59 billion
Laparoscopic Device Market Value for 2034 US$ 20.5 billion
Laparoscopic Device Market Forecast CAGR for 2024 to 2034 4.2%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Highlights of the Laparoscopic Device Industry

  • Advantages over open surgeries, like smaller incisions, less discomfort after surgery, shorter hospital stays, and quicker recovery times, laparoscopic treatments have become the procedure of choice for many surgeries.
  • The need for laparoscopic surgeries is being driven by conditions like obesity, gastrointestinal issues, and different forms of cancer.
  • Governments and the private healthcare sector are investing in healthcare infrastructure and technologies, including laparoscopic equipment to enhance patient outcomes and lower healthcare costs related to lengthier hospital stays and post-operative problems.

Historical Performance and Future Growth of the Laparoscopic Device Market

Historical CAGR 5.3%
Forecast CAGR 4.2%

The historical CAGR of the laparoscopic device market was 5.3%, indicating a moderate growth rate over the past few years. The forecast CAGR is expected to be 4.2%, indicating a slight yet steady fall in the growth rate through 2034.

  • Growth in disposable incomes, better healthcare infrastructure, and boost in knowledge of less invasive surgical procedures are contributing to the laparoscopic device market economies.
  • A rise in emphasis on enhancement on the safety and efficacy of laparoscopic procedures can be seen on value-based healthcare.

The forecast CAGR of 4.2% indicates a significant fall in the growth rate of the market in comparison to the historical CAGR in the future. The decline in CAGR can be attributed to several factors, including

  • The market may be reaching a point of saturation in certain regions or segments due to the boom in adoption of laparoscopic devices, which further results in slower growth rates.
  • Healthcare spending and investment in medical equipment are mainly impacted by economic downturns or uncertainties in important markets, leading to slower growth rates than in previous years.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Key Threats Hindering the Laparoscopic Device Market

  • Rapid advancements in technology, like emergence of robotic-assisted surgery and alternative minimally invasive techniques, could restrict the demand for traditional laparoscopic devices.
  • Intense competition among key players lead to pricing pressures, erosion of profit margins, and challenges in market share retention.
  • Reduction in reimbursement rates or restrictions on coverage for laparoscopic surgeries dampen the healthcare providers from investing in laparoscopic devices, affecting market growth.
  • High-profile product recalls or safety warnings may lead to defamation of the reputed manufacturers and deter future adoption of their devices, impacting market growth.

Comparative View of the Adjacent Laparoscopic Device Market

This section compares the laparoscopic device industry, the pain management devices market, and the portable medical devices market.

Pain management devices, like neurostimulators, implantable drug delivery systems, and radiofrequency ablation devices, essay non-pharmacological approaches to pain relief, driving the market growth.

Portable devices like digital stethoscopes, handheld ultrasound devices, and smartphone-compatible diagnostic tools expedite delivery in remote healthcares.

Laparoscopic Device Market:

Attributes Laparoscopic Device Market
CAGR from 2024 to 2034 4.2%
Opportunity Opportunities exist for broadening the applications of laparoscopic techniques across various surgical specialties, like gynecology, urology, etc.
Key Trends Integrating robotics and automation enable surgeons in performing complex procedures with greater precision and control.

Pain Management Devices Market:

Attributes Pain Management Devices Market
CAGR from 2022 to 2032 9%
Opportunity An increase in demand for effective pain management solutions leads due to aging population and rising incidence of chronic diseases.
Key Trends Adoption of wireless and wearable pain management devices is surging by offering patients mobility and flexibility in managing their pain.

Portable Medical Devices Market:

Attributes Portable Medical Devices Market
CAGR from 2023 to 2033 10.7%
Opportunity Rapid and accurate point-of-care testing, allow healthcare providers in making timely treatment decisions in various clinical settings.
Key Trends Miniaturization and wearability of portable medical devices, make the patients more convenient and comfortable to use in their daily lives.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

The table analyses the top five countries ranked by revenue, with India holding the top position.

Due to robust medical tourism industry, cost-effective yet high-quality healthcare services are offered.

India attracts a significant number of international patients seeking minimally invasive surgical procedures performed using laparoscopic devices.

Forecast CAGRs from 2024 to 2034

Countries CAGR from 2024 to 2034
The United States 2.6%
Canada 4%
France 3%
Thailand 5.8%
India 6.2%

Minimally Invasive Surgery (MIS) Drive the United States Market

  • Minimal invasive surgical procedures, including gynecology, urology, general surgery, and bariatric surgery are taking place where laparoscopic devices are extensively used in the United States.
  • Common laparoscopic procedures are performed in the United States include laparoscopic cholecystectomy (gallbladder removal), laparoscopic appendectomy, laparoscopic hysterectomy, and laparoscopic colectomy.

Surgical Specialties Impresses the Market Growth in Canada

  • Laparoscopic devices are extensively utilized across a wide range of surgical specialties, like general surgery, urology, gynecology, and gastroenterology.
  • Laparoscopic procedures including laparoscopic hernia repair, laparoscopic prostatectomy, laparoscopic ovarian cystectomy, and laparoscopic colorectal surgery are often performed in healthcare facilities in Canada.

Gynecological Surgery Drives the Market in France

  • A large percentage of laparoscopic equipment is used for treatments including laparoscopic hysterectomy, myomectomy, and endometriosis therapy as France is recognized for its proficiency in laparoscopic gynecological surgery.
  • Laparoscopic techniques are required in gynecological treatments, which are also used for pelvic floor repair, ovarian cystectomy, and tubal ligation.

Thailand Market Boosts Medical Tourism

  • Thailand has become a well-liked travel destination for medical tourism, which majorly includes laparoscopic surgery and other minimally invasive surgical treatments.
  • International patients travel to the nation for accessing high-quality and reasonably priced healthcare services, including laparoscopic procedures.

Affordable Healthcare Raises the Market Growth in India

  • Laparoscopic instruments are important due to the provision of accessible and reasonably priced healthcare facilities in India, especially in tertiary care hospitals and metropolitan areas.
  • India comprises of a wide range of patients that receive laparoscopic procedures, including laparoscopic gallbladder removal, laparoscopic hernia repair, laparoscopic hysterectomy, and laparoscopic bariatric surgery.

Category-wise Insights

The below section shows the leading segment. Based on product type, the direct energy system device is accounted to hold a market share of 28.5% in 2024. Based on application, the bariatric surgery segment is accounted to hold a market share of 28% in 2024.

The growth of direct energy system devices is fueled by the ability to provide surgeons which explicitly control over effective tissue sealing and cutting capabilities.

Bariatric surgery is becoming more popular as it provides a practical way in losing weight and addressing comorbidities associated with obesity.

Category Market Share in 2024
Direct Energy System Device 28.5%
Bariatric Surgery 28%

Direct Energy System Device to Hold a Significant Share in the Market

In 2024, the direct energy system device segment has a market share of 28.5%. The devices play a demanding role in minimally invasive surgeries, which offer precise control and effective tissue sealing and cutting capabilities by the surgeons.

Technological developments and rise in the usage of direct energy system devices by medical facilities have made vital instruments for a variety of surgical procedures, which has highly boosted their market domination.

Bariatric Surgery Segment to Hold a Dominant Share in the Market

The bariatric surgery segment holds a market share of 28% in 2024, reflecting the boost in demand for laparoscopic procedures by addressing obesity-related health concerns. Bariatric surgeries, like gastric bypass and sleeve gastrectomy, lead to utilization of laparoscopic techniques in reducing the size of the stomach by promoting weight loss.

With rise in obesity rates and growth in the awareness of the benefits of minimally invasive approaches, the bariatric surgery segment is anticipated to continue its strong growth trajectory in the coming years.

Competitive Landscape

Innovative companies are disrupting traditional players by introducing novel technologies and approaches in the laparoscopic device market. Startups are ascending advancements in robotics, artificial intelligence, and miniaturization for developing cutting-edge laparoscopic devices offering improved precision, efficiency, and patient outcomes.

Startups hence focus on niche segments or specialize in specific aspects of laparoscopic surgery, like imaging systems, energy devices, or surgical robotics.

Key developments in the laparoscopic device industry

  • In February 2023, Asensus Surgical, Inc. announced a Memorandum of Understanding with KARL STORZ VentureONE Pte. Ltd., that focused on endoscopes and laparoscopic vision systems.
  • In January 2022, Seger Surgical Solutions developed the LAP IA 60 device for intracorporeal anastomosis. The device efficiently aligned, sealed, and stapled intracorporeal anastomosis openings, which offered a secure and rapid solution without the need for internal fixation.

Key Coverage in the Laparoscopic Device Industry Report

  • Adjacent Study on Laparoscopic Device Market, Laparoscopy Instruments Market
  • Industry Analysis of Laparoscopy and Endoscopy Devices
  • Laparoscopic Device Market Size, Current Insights, and Demographic Trends
  • Demand for Laparoscopic Device Market
  • Key Strategies in Global Laparoscopic Device Market

Report Scope

Attributes Details
Estimated Market Size in 2024 US$ 13.59 billion
Projected Market Valuation in 2034 US$ 20.5 billion
Value-based CAGR 2024 to 2034 4.2%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis Value in US$ billion
Key Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa
Key Market Segments Covered
  • Product
  • Therapeutic Application
  • End-user
  • Region
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC countries
  • South Africa
  • Israel
Key Companies Profiled
  • Olympus Corporation
  • B. Braun Melsungen AG
  • Intuitive Surgical Inc.
  • Medtronic plc.
  • Stryker Corporation
  • Smith & Nephew Plc
  • CareFusion Corporation
  • Ethicon US, LLC
  • Tekno-Medical Optik Surgery GmbH
  • Richard Wolf GmbH
  • Endocontrol SA

Key Segments

By Product:

  • Direct Energy System Devices
  • Trocars/Access Device
  • Internal Closure Devices
  • Laparoscopes
  • Hand Access Instruments
  • Insufflation Devices
  • Robotic Assisted Surgical System

By Therapeutic Application:

  • Bariatric Surgery
  • Colorectal Surgery
  • General Surgery
  • Gynecological Surgery
  • Urological Surgery

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

What is the expected worth of the laparoscopic device market in 2024?

As of 2024, the market for laparoscopic devices is expected to be valued at US$ 13.59 billion.

What is the market potential for laparoscopic devices?

The Laparoscopic Device market is projected to expand at a CAGR of 4.2% between 2024 and 2034.

Which product type segment dominates the laparoscopic device market?

The direct energy system device segment is projected to dominate the industry.

What is the anticipated market value for laparoscopic device in 2034?

By 2034, the market value of laparoscopic device is expected to reach US$ 20.5 billion.

Which country is likely to dominate the laparoscopic device market?

India is likely the top-performing market, with a CAGR of 6.2%.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Manufacturer

            3.5.1.2. Mid-Level Participants (Traders)

            3.5.1.3. Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Distributors

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034

        5.3.1. Direct Energy System Devices

        5.3.2. Trocars/Access Device

        5.3.3. Internal Closure Devices

        5.3.4. Laparoscopes

        5.3.5. Hand Access Instruments

        5.3.6. Insufflation Devices

        5.3.7. Robotic Assisted Surgical System

    5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapeutic Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Therapeutic Application, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Therapeutic Application, 2024 to 2034

        6.3.1. Bariatric Surgery

        6.3.2. Colorectal Surgery

        6.3.3. General Surgery

        6.3.4. Gynecological Surgery

        6.3.5. Urological Surgery

    6.4. Y-o-Y Growth Trend Analysis By Therapeutic Application, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Therapeutic Application, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Centers

        7.3.3. Clinics

    7.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Therapeutic Application

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Therapeutic Application

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Therapeutic Application

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Therapeutic Application

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product

        11.2.3. By Therapeutic Application

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Therapeutic Application

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product

        12.2.3. By Therapeutic Application

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Therapeutic Application

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product

        13.2.3. By Therapeutic Application

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Therapeutic Application

        13.3.4. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product

        14.2.3. By Therapeutic Application

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Therapeutic Application

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Therapeutic Application

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Therapeutic Application

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2023

            16.1.2.1. By Product

            16.1.2.2. By Therapeutic Application

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2023

            16.2.2.1. By Product

            16.2.2.2. By Therapeutic Application

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2023

            16.3.2.1. By Product

            16.3.2.2. By Therapeutic Application

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2023

            16.4.2.1. By Product

            16.4.2.2. By Therapeutic Application

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2023

            16.5.2.1. By Product

            16.5.2.2. By Therapeutic Application

            16.5.2.3. By End User

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2023

            16.6.2.1. By Product

            16.6.2.2. By Therapeutic Application

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2023

            16.7.2.1. By Product

            16.7.2.2. By Therapeutic Application

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2023

            16.8.2.1. By Product

            16.8.2.2. By Therapeutic Application

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2023

            16.9.2.1. By Product

            16.9.2.2. By Therapeutic Application

            16.9.2.3. By End User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2023

            16.10.2.1. By Product

            16.10.2.2. By Therapeutic Application

            16.10.2.3. By End User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2023

            16.11.2.1. By Product

            16.11.2.2. By Therapeutic Application

            16.11.2.3. By End User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2023

            16.12.2.1. By Product

            16.12.2.2. By Therapeutic Application

            16.12.2.3. By End User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2023

            16.13.2.1. By Product

            16.13.2.2. By Therapeutic Application

            16.13.2.3. By End User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2023

            16.14.2.1. By Product

            16.14.2.2. By Therapeutic Application

            16.14.2.3. By End User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2023

            16.15.2.1. By Product

            16.15.2.2. By Therapeutic Application

            16.15.2.3. By End User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2023

            16.16.2.1. By Product

            16.16.2.2. By Therapeutic Application

            16.16.2.3. By End User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2023

            16.17.2.1. By Product

            16.17.2.2. By Therapeutic Application

            16.17.2.3. By End User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2023

            16.18.2.1. By Product

            16.18.2.2. By Therapeutic Application

            16.18.2.3. By End User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2023

            16.19.2.1. By Product

            16.19.2.2. By Therapeutic Application

            16.19.2.3. By End User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2023

            16.20.2.1. By Product

            16.20.2.2. By Therapeutic Application

            16.20.2.3. By End User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2023

            16.21.2.1. By Product

            16.21.2.2. By Therapeutic Application

            16.21.2.3. By End User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2023

            16.22.2.1. By Product

            16.22.2.2. By Therapeutic Application

            16.22.2.3. By End User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2023

            16.23.2.1. By Product

            16.23.2.2. By Therapeutic Application

            16.23.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Therapeutic Application

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Olympus Corporation

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. B. Braun Melsungen AG

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Intuitive Surgical Inc.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Medtronic plc.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Stryker Corporation

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Smith & Nephew Plc

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. CareFusion Corporation

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Ethicon US, LLC

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Tekno-Medical Optik Surgery GmbH

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Richard Wolf GmbH

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. Endocontrol SA

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Laparoscopic Gynecological Procedures Market

May 2022

REP-GB-14778

June 2024

250 pages

Healthcare

Reusable Laparoscopic Instruments Market

July 2023

REP-GB-17605

250 pages

Healthcare

Portable Medical Devices Market

March 2018

REP-GB-404

February 2023

313 pages

Healthcare

Pain Management Devices Market

February 2022

REP-GB-14306

October 2022

315 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Laparoscopic Device Market